Cordis releases cobalt chromium Palmaz Blue biliary stent in the US:
This article was originally published in Clinica
Cordis has launched in the US its balloon-expandable Palmaz Blue transhepatic biliary cobalt chromium stent for opening blocked bile ducts. Featuring L605, a cobalt alloy enhanced with tungsten, the device is stronger than stainless steel stents and uses less metal, claims the company. As well as being stronger, the stent has a low profile and offers improvements in radiopacity, flexibility and deliverability, the firm added. Cordis, a Johnson & Johnson company, said that each year in the US, over 30,000 people are affected by life-threatening bile duct blockages.f
You may also be interested in...
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.